Peripheral neuropathy Board decisions

The Board granted a 40 percent disability rating for the left and right lower extremity sciatic peripheral neuropathy from April 19, 2022, but denied increased ratings for all other conditions.

The Board denied earlier effective dates for the grants of service connection for diabetic peripheral neuropathy and voiding dysfunction, as well as remanded claims for increased ratings.

The Board remands the claim for an addendum opinion to address the etiology of the Veteran's ischemic optic neuropathy, specifically regarding its relation to in-service herbicide exposure.

The Board granted service connection for skin cancer on the back, ears, forehead, cheeks and remanded claims for right shoulder disability, bilateral hearing loss disability, left lateral epicondylitis and ulnar neuropathy (left elbow disability), and left and right foot plantar fasciitis (feet disability).

The Board denied the claims for service connection for rectal cancer and various types of neuropathy, finding that the evidence did not support a causal relationship between these conditions and the Veteran's active duty service.

The Veteran is granted special monthly compensation (SMC) based on a need for aid and attendance due to service-connected disabilities, which includes PTSD, diabetes, hearing loss, and other conditions.

The Board remands the Veteran's claims for service connection for bilateral lower extremity neuropathy due to a pre-decisional error in the duty to assist.

The Board granted an effective date of December 7, 2021, for the award of TDIU and DEA benefits.

The Board remands the claims for service connection for a thoracolumbar condition, mononeuropathy of the sciatic nerve, and glaucoma to obtain an adequate medical opinion.

The Board granted service connection for right and left lower extremity diabetic neuropathy, but denied a higher rating for type II diabetes mellitus. The claims for increased ratings of upper extremity peripheral neuropathy and psychiatric disability were remanded.

The Board granted service connection for bilateral peripheral neuropathy of the hands and feet, finding a relationship to herbicide agent exposure during the Vietnam War era.

The Board granted service connection for left and right lower extremity peripheral neuropathy, to include as due to herbicide exposure.

The Board granted service connection for degenerative arthritis in the right knee, degenerative arthritis in the lower back, and bilateral lower extremity peripheral neuropathy. The claim for an eye disorder was denied.

The Board granted service connection for peripheral neuropathy of the right and left upper and lower extremities, all presumed to be due to exposure to herbicide agents during service in Vietnam.

The Board denied service connection for lumbar spine intervertebral osteochondrosis, diabetes mellitus, type II (DMII), and bilateral lower extremity peripheral neuropathy.

The Board granted service connection for right and left lower extremity neuropathy, both related to the Veteran's in-service herbicide exposure.

The Board denied the veteran's claims for higher initial ratings for peripheral neuropathy of both sciatic and femoral nerves in his lower extremities, finding that the evidence did not support a moderate level of incomplete paralysis.

The Board remands the case to provide a VA examination to determine the medical significance of certain records and opinions regarding the Veteran's disabilities.

The Veteran is granted an earlier effective date of November 27, 2023, for service connection of bilateral lower extremity peripheral neuropathy. The claim for a rating before July 7, 2025, was denied.

The Board granted service connection for left ulnar peripheral neuropathy and denied a higher rating for left lateral epicondylitis.